ZLY28 is a First-in-Class FXR/FABP1 Dual Modulator for the Research of NASH
Nonalcoholic fatty liver disease (NAFLD), characterized by excessive accumulation of fat in hepatocytes, is a common chronic liver disease including a wide spectrum of disorders ranging from nonalcoholic fatty liver…